Provided by Tiger Fintech (Singapore) Pte. Ltd.

CVRx, Inc.

7.67
-0.1300-1.67%
Volume:33.77K
Turnover:259.83K
Market Cap:200.58M
PE:-3.65
High:7.80
Open:7.73
Low:7.60
Close:7.80
52wk High:18.55
52wk Low:4.30
Shares:26.15M
Float Shares:17.96M
Volume Ratio:0.32
T/O Rate:0.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1012
EPS(LYR):-2.6538
ROE:-92.33%
ROA:-29.63%
PB:3.46
PE(LYR):-2.89

Loading ...

Company Profile

Company Name:
CVRx, Inc.
Exchange:
NASDAQ
Establishment Date:
2000
Employees:
206
Office Location:
9201 West Broadway Avenue,Suite 650,Minneapolis,Minnesota,United States
Zip Code:
55445
Fax:
763 416 2841
Introduction:
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Directors

Name
Position
Kevin Hykes
Director, President and Chief Executive Officer
Joseph Slattery
Independent Lead Director
Kevin J. Ballinger
Independent Director
Kirk Nielsen
Lead Independent Director
Martha Shadan
Independent Director
Mitchell C. Hill
Independent Director
Mudit K. Jain
Independent Director

Shareholders

Name
Position
Kevin Hykes
Director, President and Chief Executive Officer
Brent Binkowski
Chief Operating Officer
Jared Oasheim
Chief Financial Officer and Principal Accounting Officer
Paul Verrastro
Chief Marketing Officer and Chief Strategy Officer
Philip B. Adan
Chief Medical Officer
Robert Allen John
Chief Revenue Officer